Fei Wei

440 total citations
16 papers, 249 citations indexed

About

Fei Wei is a scholar working on Pulmonary and Respiratory Medicine, Neurology and Oncology. According to data from OpenAlex, Fei Wei has authored 16 papers receiving a total of 249 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 4 papers in Neurology and 4 papers in Oncology. Recurrent topics in Fei Wei's work include Cancer Immunotherapy and Biomarkers (3 papers), Ferroptosis and cancer prognosis (3 papers) and Cerebrovascular and Carotid Artery Diseases (3 papers). Fei Wei is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Ferroptosis and cancer prognosis (3 papers) and Cerebrovascular and Carotid Artery Diseases (3 papers). Fei Wei collaborates with scholars based in China and United States. Fei Wei's co-authors include Fang Yuan, Bin Xiong, Fen Hu, Yulei Wang, Juanjuan Tang, Die Wu, Xiaoke Feng, Guoliang Cui, Mu-Xin Wei and Tong Zhou and has published in prestigious journals such as Frontiers in Immunology, International Journal of Obesity and Medicine.

In The Last Decade

Fei Wei

15 papers receiving 246 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fei Wei China 9 84 57 45 44 42 16 249
Liyue Qin China 6 196 2.3× 70 1.2× 59 1.3× 39 0.9× 26 0.6× 8 394
Feiyu Chen China 8 87 1.0× 33 0.6× 48 1.1× 23 0.5× 100 2.4× 28 300
Yongfeng Chen China 7 105 1.3× 31 0.5× 38 0.8× 24 0.5× 16 0.4× 21 326
Zhengang Tang China 8 163 1.9× 26 0.5× 32 0.7× 30 0.7× 28 0.7× 14 344
Xun Sun China 12 162 1.9× 54 0.9× 69 1.5× 31 0.7× 20 0.5× 29 393
Shiming Zhang China 11 197 2.3× 42 0.7× 25 0.6× 101 2.3× 42 1.0× 30 431
Hossein Bagheri Iran 7 146 1.7× 18 0.3× 37 0.8× 48 1.1× 21 0.5× 11 433
Rayan Khaddaj‐Mallat Canada 9 97 1.2× 45 0.8× 12 0.3× 26 0.6× 18 0.4× 12 329

Countries citing papers authored by Fei Wei

Since Specialization
Citations

This map shows the geographic impact of Fei Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Wei more than expected).

Fields of papers citing papers by Fei Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Wei. The network helps show where Fei Wei may publish in the future.

Co-authorship network of co-authors of Fei Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Wei. A scholar is included among the top collaborators of Fei Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Wei. Fei Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Fang, Xiang, et al.. (2025). Effects of weight control interventions on cardiovascular outcomes: an umbrella review of systematic reviews and meta-analyses. International Journal of Obesity. 49(10). 1911–1920. 1 indexed citations
3.
Chu, Tianci, et al.. (2024). Patient delay of patients with pulmonary tuberculosis in Yantai, China, 2013 to 2022: Analysis of a case series. Medicine. 103(9). e37188–e37188. 1 indexed citations
4.
Cui, Guoliang, Jinhui Liu, Manli Wang, et al.. (2022). Crosstalk of angiogenesis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in colorectal adenocarcinoma. Frontiers in Immunology. 13. 1049485–1049485. 3 indexed citations
5.
Cui, Guoliang, et al.. (2021). Prognostic and immunological role of Ras-related protein Rap1b in pan-cancer. Bioengineered. 12(1). 4828–4840. 19 indexed citations
6.
Cui, Guoliang, et al.. (2021). CFP is a prognostic biomarker and correlated with immune infiltrates in Gastric Cancer and Lung Cancer. Journal of Cancer. 12(11). 3378–3390. 10 indexed citations
8.
Tang, Juanjuan, Hou Liu, Wenda Xue, et al.. (2020). Crocin Reverses Depression-Like Behavior in Parkinson Disease Mice via VTA-mPFC Pathway. Molecular Neurobiology. 57(7). 3158–3170. 45 indexed citations
9.
10.
Zhou, Yu, Li Wang, Jianrong Zhang, et al.. (2019). Angioplasty and stenting for severe symptomatic atherosclerotic stenosis of intracranial vertebrobasilar artery. Journal of Clinical Neuroscience. 63. 17–21. 11 indexed citations
11.
Ye, Lei, Huanhuan Ren, Xiaoyu Chen, et al.. (2019). Alteronol Enhances the Anti-tumor Activity and Reduces the Toxicity of High-Dose Adriamycin in Breast Cancer. Frontiers in Pharmacology. 10. 285–285. 8 indexed citations
12.
13.
Wei, Fei, et al.. (2017). [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].. PubMed. 39(7). 524–527. 1 indexed citations
14.
Jing, Xiaogang, Fei Wei, Jing Li, et al.. (2017). Diagnostic value of soluble B7‐H4 and carcinoembryonic antigen in distinguishing malignant from benign pleural effusion. The Clinical Respiratory Journal. 12(3). 986–990. 8 indexed citations
15.
Zhao, Ting, Xiao‐Yi Xiong, Jie Li, et al.. (2016). Safety and Efficacy of Wingspan Stenting for Severe Symptomatic Atherosclerotic Stenosis of the Middle Cerebral Artery: Analysis of 278 Continuous Cases. Journal of Stroke and Cerebrovascular Diseases. 25(10). 2368–2372. 17 indexed citations
16.
Hu, Fen, et al.. (2015). EGCG synergizes the therapeutic effect of cisplatin and oxaliplatin through autophagic pathway in human colorectal cancer cells. Journal of Pharmacological Sciences. 128(1). 27–34. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026